We’re here to transform your CDMO experience.
We’re here to transform the CDMO experience.
We’re here to completely transform your CDMO experience.
ABOUT US
Our clients are our top priority.
For decades Avid Bioservices has been collaborating with clients to deliver high-quality, reliable contract development and manufacturing services. We’re continually innovating to create a truly personalized CDMO experience for those who partner with us.
1993
Began biologics development and manufacturing as Peregrine Pharmaceuticals
2002
Formed Avid Bioservices, Inc. as a wholly owned subsidiary of Peregrine Pharmaceuticals
2003
Signed first client for manufacturing services
2005
Received first FDA commercial approval
2018
Avid Bioservices Inc. launched as a dedicated, independent biologics manufacturer (NASDAQ:CDMO)
2023
2025
Avid Bioservices Inc. acquired by GHO Capital Partners and Ampersand Capital Partners
1993
Began biologics development and manufacturing as Peregrine Pharmaceuticals
2002
Formed Avid Bioservices, Inc. as a wholly owned subsidiary of Peregrine Pharmaceuticals
2003
Signed first client for manufacturing services
2005
Received first FDA commercial approval
2018
Avid Bioservices Inc. launched as a dedicated, independent biologics manufacturer (NASDAQ:CDMO)
2023
Commissioned mammalian protein CGMP Drug Substance Line 3 facility
2025
Avid Bioservices Inc. acquired by GHO Capital Partners and Ampersand Capital Partners
leadership
Always moving forward.
FACILITIES
State-of-the-art facilities.
We offer advanced mammalian protein development and sophisticated commercial manufacturing.
Leadership
Always moving forward.
Facilities
State-of-the-art facilities.
We offer advanced mammalian protein development and sophisticated commercial manufacturing.
Join our team.
A career with Avid Bioservices is an investment in your own potential and a commitment to improve patients’ lives.
Environmental, Social, and Governance
We aim to enable a better quality of life by acting responsibly and preserving our world for future generations.